Healthtech funding in H1 2014

European Healthtech startup funding raised during H1 2014.

In H1 2014, 68 European Healthtech companies closed 70 funding rounds and raised €387M in equity funding (excluding debt and grants), up 27.8% versus H1 2013. Debt rounds added €649k. Switzerland led by capital raised, and Imprimatur Capital was the most active investor. Data as of 6 Nov 2026.

Equity funding

€387M

+27.8% vs H1 2013 · excl. debt & grants · +€649k debt

Funding rounds

+18.6% vs H1 2013

Companies

Top country

Switzerland

Rank among sectors

6.7% of sector funding

Debt financing

€649k

0.2% of total

Top-10 round share

66.2%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jan	€64M	12
Feb	€70M	7
Mar	€23M	11
Apr	€151M	17
May	€66M	11
Jun	€14M	12

Top countries

by € raised

Data table

	Healthtech — top countries by capital, H1 2014
Switzerland	€119M
Sweden	€86M
France	€66M
UK	€44M
Israel	€20M
Finland	€20M
Belgium	€12M
Spain	€5.6M

Stage mix

by € raised

Data table

	Healthtech — stage mix, H1 2014
Series D+	€119M
Other	€101M
Series B	€53M
Series A	€46M
Growth/Late	€22M
Seed	€19M
Series C	€17M
Early VC	€8.8M
Grant	€1.7M
Debt	€649k

Exits & M&A

1 Acquisition

1 exit.

Top deals

largest disclosed rounds in H1 2014

Company	Stage	Date	Amount
NovImmune	Series D+	Feb 2014	€49M
Wilson Therapeutics	Other	Apr 2014	€36M
uTest_Vamsi	Series D+	Jan 2014	€31M
Kymab	Series B	May 2014	€29M
CRISPR Therapeutics	Series A	Apr 2014	€23M
Voluntis	Series D+	Apr 2014	€21M
InDex Pharmaceuticals	Other	Feb 2014	€18M
AC Immune	Series D+	Jan 2014	€18M
Sequana Medical	Series C	Apr 2014	€17M
Bima	Series B	Apr 2014	€16M
Lifeline Ventures Oy	Other	Apr 2014	€15M
OrCam	Growth/Late	Mar 2014	€11M
Enterome	Other	May 2014	€10M
Nyxoah	Series A	May 2014	€8.0M
OxThera	Other	Apr 2014	€7.7M

View all 70 Healthtech deals in H1 2014 →

Top investors

most active in H1 2014, by deal count

← All 2014 Healthtech funding